Increased cyclin E level in retinoblastoma cells during programmed cell death.
Camptothecin (an inhibitor of topoisomerase I) and etoposide and amsacrine (inhibitors of topoisomerase II) both capable of triggering programmed cell death in Y79 cells, induced a remarkable dose-dependent increase in the level of cyclin E in these cells. Camptothecin was found to be the most effective compound. The effect was not observed when the cells were treated with other inducers of programmed cell death (C2-ceramide, sodium butyrate, interleukin-1beta and tumor necrosis factor), all of which do not damage DNA. The effect, which was completely prevented by inhibitors of macromolecular synthesis, occurred after a lag phase (12 hrs.) and increased concurrently with the rise in programmed cell death (PCD), reaching a maximum after 36 hrs. of incubation, when a large percentage of cells (95%) showed clear PCD signals. We suggest that cyclin E takes part in the final stage of programmed cell death which is induced by topoisomerase inhibitors in Y79 cells.
Lauricella
M
M
Institute of Biological Chemistry, University of Palermo, Policlinico, Italy.
Giuliano
M
M
Emanuele
S
S
Carabillò
M
M
Vento
R
R
Tesoriere
G
G
D000677:Amsacrine / Q000378:metabolism; D017209:Apoptosis / Q000502:physiology*; D002166:Camptothecin / Q000378:metabolism; D019925:Cyclin A / Q000187:drug effects / Q000378:metabolism; D019927:Cyclin E / Q000187:drug effects / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005047:Etoposide / Q000378:metabolism; D006801:Humans; D007375:Interleukin-1; D012175:Retinoblastoma / Q000378:metabolism* / Q000473:pathology; D013110:Sphingosine / Q000031:analogs & derivatives / Q000378:metabolism; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D019925:Cyclin A; D019927:Cyclin E; D004791:Enzyme Inhibitors; D007375:Interleukin-1; C064769:N-acetylsphingosine; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D014409:Tumor Necrosis Factor-alpha; D000677:Amsacrine; D005047:Etoposide; D013110:Sphingosine; D002166:Camptothecin